It means that larger companies and investors will take BMSN more seriously. This means that it'll be easier to attract the investors needed or to do a "Joint Venture" with larger Biopharms for their trials.
Basically, OTC Pink vs OTC QB is kind of like a mini version of NASDAQ vs OTC.
News 
Market Data 
Discover 
AI
